Impact of facility size and profit status on intermediate outcomes in chronic dialysis patients

Am J Kidney Dis. 2000 Aug;36(2):318-26. doi: 10.1053/ajkd.2000.8981.

Abstract

Little information is available regarding the influence of dialysis facility size or profit status on intermediate outcomes in chronic dialysis patients. We have combined data from the Health Care Financing Administration (HCFA) Core Indicators Project; the end-stage renal disease (ESRD) facility survey; and the HCFA On-Line Survey, Certification, and Reporting System to analyze trends in this area. For hemodialysis patients, larger facilities were more likely than smaller facilities to perform dialysis on patients who were younger than 65 years of age, black, or undergoing dialysis 2 years or more (P < 0.001). Nonprofit facilities were more likely to perform dialysis on patients with diabetes mellitus as a cause of ESRD and less likely to perform dialysis on patients with hypertension as a cause of ESRD compared with for-profit units (P < 0.05). By multivariate analysis, larger facility size was modestly associated with a greater Kt/V value and urea reduction ratio, but not with hematocrit or serum albumin values. Facility profit status was not associated with these intermediate outcomes. For peritoneal dialysis patients, there were no significant differences in patient demographics based on facility size. More patients in nonprofit units had been undergoing dialysis 2 or more years than patients in for-profit units (P < 0.05). By univariate analysis, patients in larger facilities were more likely to have an adequacy measure performed than patients from smaller facilities (P < 0.05). There were few substantial differences in intermediate outcomes in chronic dialysis patients based on facility size or profit status.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anemia / etiology
  • Anemia / therapy
  • Creatinine / metabolism
  • Female
  • Health Facilities / economics*
  • Health Facility Size*
  • Hematocrit
  • Humans
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / metabolism
  • Kidney Failure, Chronic / therapy*
  • Logistic Models
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care
  • Renal Dialysis*
  • Serum Albumin / analysis
  • Urea / metabolism

Substances

  • Serum Albumin
  • Urea
  • Creatinine